Automated manufacture of ΔNPM1 TCR-engineered T cells for AML therapy

ABSTRACT:

SUBMITTER: Yonezawa Ogusuku I 

PROVIDER: S-EPMC10950868 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature